Javelin Minerals Limited (JAV.AX)
AUD 0.0
(0.0%)
AUD 0.0
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -549.7 Thousand | -707.39 Thousand | -3.38 Million | -2.26 Million | -835.93 Thousand | -1.07 Million |
| Net Income | -3.79 Million | -660.09 Thousand | -976.63 Thousand | -639.97 Thousand | -471.21 Thousand | -13.09 Million |
| Depreciation & Amortization | 2.87 Million | 23.69 | 315.47 | - | 1335.00 | 3278.00 |
| Deferred income taxes | - | - | - | - | -53.85 Thousand | - |
| Stock-based compensation | - | - | - | 146.5 Thousand | 36 Thousand | - |
| Change in working capital | 85.57 Thousand | -70.99 Thousand | -2.75 Million | -1.77 Million | -567.99 Thousand | -342.61 Thousand |
| Other non-cash items | 279.19 Thousand | 23.66 Thousand | 340.15 Thousand | 146.35 Thousand | 255.75 Thousand | 12.35 Million |
| Investing Cash Flow | -1.05 Million | -1.43 Million | -2549.57 | - | - | -4029.00 |
| Investments in PPE | -1.05 Million | -1.43 Million | -2549.57 | - | - | -4029.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -5395.00 | -1.43 Million | - | - | - | - |
| Financing Cash Flow | 1.82 Million | - | 4.97 Million | 2.59 Million | 1.37 Million | 393.68 Thousand |
| Debt repayment | - | - | - | - | - | -200 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -276.06 Thousand | -126.92 Thousand | -235.74 Thousand | -18.26 Thousand |
| Common Stock Issuance | 1.82 Million | - | 5.25 Million | 2.6 Million | 1.61 Million | 211.94 Thousand |
| Other Financing Activities | 1.82 Million | - | 4978.84 | 120 Thousand | 1376.99 | 200 Thousand |
| Accounts receivables | 42.24 Thousand | -585.00 | -2115.00 | -13.11 Thousand | -33.58 Thousand | -15.97 Thousand |
| Accounts payables | 150.3 Thousand | -37.01 Thousand | - | 162.82 Thousand | -17.56 Thousand | -109.12 Thousand |
| Inventory | - | - | - | - | -1.00 | -1.00 |
| Other working capital | 43.32 Thousand | -33.38 Thousand | -2.75 Million | -1.92 Million | -516.84 Thousand | -217.51 Thousand |
| Cash at beginning of period | 444.86 Thousand | 2.58 Million | 993.21 Thousand | 670.04 Thousand | 128.98 Thousand | 818.55 Thousand |
| Cash at end of period | 663.73 Thousand | 444.86 Thousand | 2.58 Million | 993.21 Thousand | 670.04 Thousand | 128.98 Thousand |
| Capital Expenditure | -1.05 Million | -1.43 Million | -2549.57 | - | - | -4029.00 |
| Effect of forex changes on cash | - | - | 2549.56 | - | - | - |
| Net cash flow / Change in cash | 218.87 Thousand | -2.13 Million | 1.58 Million | 323.17 Thousand | 541.05 Thousand | -689.57 Thousand |
| Free Cash Flow | -1.6 Million | -2.13 Million | -3.39 Million | -2.26 Million | -835.93 Thousand | -1.08 Million |
| Breakdown | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1619.41 | -1619.41 | -276.84 | -276.84 | -289.41 Thousand | -660.09 Thousand |
| Depreciation & Amortization | 1427.70 | 1427.70 | 11.31 | 11.31 | 9.00 | 23.69 |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 42.79 | 42.79 | - | - | -16.99 | -70.99 Thousand |
| Other non-cash items | -83.43 | -83.43 | 223.02 | 223.02 | 562.17 Thousand | 23.66 Thousand |
| Investing Cash Flow | -136.21 | -136.21 | -392.60 | -392.60 | -1.43 Million | -1.43 Million |
| Investments in PPE | -136.21 | -136.21 | -392.60 | -392.60 | -1.43 Million | -1.43 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 666.86 | 666.86 | 246.24 | 246.24 | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 492.48 Thousand | - | - | - |
| Other Financing Activities | 666.86 | 666.86 | 246.24 | 246.24 | - | - |
| Accounts receivables | 21.12 | 21.12 | - | - | -0.29 | -585.00 |
| Accounts payables | - | - | - | - | - | -37.01 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 21.66 | 21.66 | - | - | -16.70 | -33.38 Thousand |
| Cash at beginning of period | - | - | 444.86 Thousand | - | 1.6 Million | 2.58 Million |
| Cash at end of period | 298.29 | 298.29 | 67.14 Thousand | -188.86 | 444.86 Thousand | 444.86 Thousand |
| Capital Expenditure | -136.21 | -136.21 | -392.60 | -392.60 | -1.43 Million | -1.43 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 298.29 | 298.29 | -377.71 Thousand | -188.86 | -1.15 Million | -2.13 Million |
| Free Cash Flow | -368.56 | -368.56 | -435.10 | -435.10 | -1.15 Million | -2.13 Million |
7971
4599
PKBFF
HEALTHYLIFE
7897
IXOG